These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 5775990)

  • 1. The influence of debrisoquin on the accumulation and metabolism of biogenic amines by the human platelet, in vivo and in vitro.
    Solomon HM; Ashley C; Spirt N; Abrams WB
    Clin Pharmacol Ther; 1969; 10(2):229-38. PubMed ID: 5775990
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of debrisoquin, guanethidine and tyramine on platelet function and blood coagulation.
    Zbinden G; Tomlin S
    Arch Int Pharmacodyn Ther; 1969 Sep; 181(1):153-69. PubMed ID: 5350778
    [No Abstract]   [Full Text] [Related]  

  • 3. Accumulation of debrisoquin-14C by the human platelet.
    Pocelinko R; Solomon HM
    Biochem Pharmacol; 1970 Mar; 19(3):697-703. PubMed ID: 5507678
    [No Abstract]   [Full Text] [Related]  

  • 4. Debrisoquin, a selective inhibitor of intraneuronal monoamine oxidase in man.
    Pettinger WA; Korn A; Spiegel H; Solomon HM; Pocelinko R; Abrams WB
    Clin Pharmacol Ther; 1969; 10(5):667-74. PubMed ID: 5808462
    [No Abstract]   [Full Text] [Related]  

  • 5. The human platelet as a pharmacologic model for the adrenergic neuron. The uptake and release of norepinephrine.
    Abrams WB; Solomon HM
    Clin Pharmacol Ther; 1969; 10(5):702-9. PubMed ID: 4390109
    [No Abstract]   [Full Text] [Related]  

  • 6. [Study of antimonoamine oxidase action and pharmacological properties of 2,3-dihydro-1H-benz[d,e]isoquinoline hydrochloride].
    Gorkin VZ; Tochilkin AI; Andreeva NI; Mashkovskiĭ MD; Zhuravleva GV
    Farmakol Toksikol; 1974; 37(6):651-5. PubMed ID: 4464086
    [No Abstract]   [Full Text] [Related]  

  • 7. Proceedings: Influence of MAO-inhibitors on the intestinal absorption of biogenic amines.
    Huebers H; Huebers E; Huebers U; Rummel W
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 282(Suppl):suppl 282:R36. PubMed ID: 4276566
    [No Abstract]   [Full Text] [Related]  

  • 8. Influence of substrate in the inhibition of rat liver and brain monoamine oxidase.
    Fuller RW
    Arch Int Pharmacodyn Ther; 1968 Jul; 174(1):32-7. PubMed ID: 4386711
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of 5,6-dihydroxytryptamine on uptake, storage and metabolism of 5-hydroxytryptamine by blood platelets.
    Da Prada M; O'Brien RA; Tranzer JP; Pletscher A
    J Pharmacol Exp Ther; 1973 Aug; 186(2):213-9. PubMed ID: 4719776
    [No Abstract]   [Full Text] [Related]  

  • 10. Metabolism of biogenic amines in Drosophila nervous tissue.
    Dewhurst SA; Croker SG; Ikeda K; McCaman RE
    Comp Biochem Physiol B; 1972 Dec; 43(4):975-81. PubMed ID: 4662578
    [No Abstract]   [Full Text] [Related]  

  • 11. The effect of monoamine oxidase inhibitors on 'first-pass' metabolism of tyramine in dog intestine.
    Ilett KF; George CF; Davies DS
    Biochem Pharmacol; 1980 Oct; 29(19):2551-6. PubMed ID: 7426061
    [No Abstract]   [Full Text] [Related]  

  • 12. On the inhibition by harmine of oxidative deamination of biogenic monoamines.
    Gorkin VZ; Tatyanenko LV
    Life Sci; 1967 Apr; 6(8):791-5. PubMed ID: 6034186
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of Monase and related compounds on uptake of 5-hydroxytryptamine by platelets.
    Burningham RA; Arimura GK; Yunis AA
    Proc Soc Exp Biol Med; 1966 Jul; 122(3):711-4. PubMed ID: 5918937
    [No Abstract]   [Full Text] [Related]  

  • 14. Differential uptake of biogenic amines by isolated 5-hydroxytryptamine organelles of blood platelets.
    Da Prada M; Pletscher A
    Life Sci; 1969 Jan; 8(1):65-72. PubMed ID: 5369582
    [No Abstract]   [Full Text] [Related]  

  • 15. [Conjugated dinitrocompound dianions as inhibitors of the oxidative deamination of monoamines].
    Gureeva ZP; Mostiaeva LV
    Biokhimiia; 1984 Nov; 49(11):1840-6. PubMed ID: 6549266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The accumulation of guanethidine by human blood platelets.
    Boullin DJ; O'Brien RA
    Br J Pharmacol; 1969 Jan; 35(1):90-102. PubMed ID: 5762045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on brain metabolism of biogenic amines.
    Schacht U; Leven M; Bäcker G
    Br J Clin Pharmacol; 1977; 4Suppl 2(Suppl 2):77S-87S. PubMed ID: 199222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the uptake of various amines into storage vesicles of intact human platelets.
    Costa JL; Murphy DL; Reveille J
    Br J Pharmacol; 1977 Oct; 61(2):223-8. PubMed ID: 922252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The monoamine oxidase inhibitory effect of new homopyrimidazole derivatives.
    Magyar K; Satory E; Meszaros Z
    Med Biol; 1974 Dec; 52(6):384-9. PubMed ID: 4444359
    [No Abstract]   [Full Text] [Related]  

  • 20. MAO-A-induced mitogenic signaling is mediated by reactive oxygen species, MMP-2, and the sphingolipid pathway.
    Coatrieux C; Sanson M; Negre-Salvayre A; Parini A; Hannun Y; Itohara S; Salvayre R; Auge N
    Free Radic Biol Med; 2007 Jul; 43(1):80-9. PubMed ID: 17561096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.